Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

638 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Comparison of cystatin C- and creatinine-based estimated glomerular filtration rate to predict coronary heart disease risk in Japanese patients with obesity and diabetes.
Ito R, Yamakage H, Kotani K, Wada H, Otani S, Yonezawa K, Ogo A, Okajima T, Adachi M, Araki R, Yoshida K, Saito M, Nagaoka T, Toyonaga T, Tanaka T, Yamada T, Ota I, Oishi M, Miyanaga F, Shimatsu A, Satoh-Asahara N; Japan Diabetes and Obesity Study (J-DOS) Group. Ito R, et al. Among authors: nagaoka t. Endocr J. 2015;62(2):201-7. doi: 10.1507/endocrj.EJ14-0352. Epub 2014 Nov 14. Endocr J. 2015. PMID: 25399862 Free article.
Serum soluble TREM2 is a potential novel biomarker of cognitive impairment in Japanese non-obese patients with diabetes.
Tanaka M, Yamakage H, Masuda S, Inoue T, Ohue-Kitano R, Araki R, Matoba Y, Saito M, Nagaoka T, Yonezawa K, Tanaka T, Suzuki M, Sawamura M, Nishimura M, Odori S, Wada H, Kotani K, Kusakabe T, Shimatsu A, Hasegawa K, Satoh-Asahara N. Tanaka M, et al. Among authors: nagaoka t. Diabetes Metab. 2019 Jan;45(1):86-89. doi: 10.1016/j.diabet.2017.06.006. Epub 2017 Jul 31. Diabetes Metab. 2019. PMID: 28774784 No abstract available.
Insulin-glucagon-like peptide-1 receptor agonist relay and glucagon-like peptide-1 receptor agonist first regimens in individuals with type 2 diabetes: A randomized, open-label trial study.
Takeshita Y, Kita Y, Tanaka T, Goto H, Nakano Y, Teramura C, Enyama Y, Takamura T; Establishment of Rationale for Antiaging Diabetic Medicine (ERA-DM) Study Group. Takeshita Y, et al. J Diabetes Investig. 2022 Jun;13(6):965-974. doi: 10.1111/jdi.13749. Epub 2022 Feb 8. J Diabetes Investig. 2022. PMID: 35034428 Free PMC article. Clinical Trial.
Inhaled insulin in type 1 diabetes.
Nagaoka T, Miyakoshi H. Nagaoka T, et al. Lancet. 2001 Jun 16;357(9272):1979. doi: 10.1016/S0140-6736(00)05049-2. Lancet. 2001. PMID: 11729843 No abstract available.
638 results